Home
Resources
Diseases
COVID-19
Hepatitis B
Human papillomavirus (HPV)
Malaria
Measles
Mpox
Pneumococcal disease
RSV (Respiratory syncytial virus)
Compendium
Hexavalent vaccines
HPV vaccines
Malaria vaccines
PCV vaccines
RSV vaccines
Training
Vaccine Portfolio Optimization and Prioritization (VPOP)
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (40)
NITAG documentation (1641)
Reports (63)
SAGE documentation (226)
Scientific publications (122)
Systematic reviews (SYSVAC) (3100)
Regions
Africa (297)
Americas (794)
Eastern Mediterranean (58)
Europe (744)
Global (1)
South-East Asia (82)
Western Pacific (216)
Diseases
Chikungunya (13)
Cholera (35)
COVID-19 (1589)
Cytomegalovirus (1)
Dengue (43)
Diphtheria (90)
Ebola (19)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (71)
Hepatitis A (69)
Hepatitis B (171)
Hepatitis C (5)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (77)
HIV / AIDS (10)
Human papillomavirus (HPV) (537)
Influenza (629)
Japanese encephalitis (34)
Lyme disease, Borreliosis (2)
Malaria (33)
Measles (144)
Meningococcal disease (155)
Moraxella catarrhalis (1)
Mpox (58)
Mumps (50)
Pertussis (120)
Pneumococcal disease (305)
Poliomyelitis (94)
Q fever (1)
Rabies (33)
Rotavirus (121)
RSV (Respiratory syncytial virus) (69)
Rubella (69)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (71)
Tick-borne encephalitis (14)
Tuberculosis (83)
Typhoid (32)
Varicella (77)
Yellow fever (44)
Zika (1)
Show more
5192 results found
2022
∙
ACIP
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022–23 Influenza Season
2022
∙
ACIP
Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations — United States, 2021
2022
∙
ACIP
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
2022
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19: Place of the VLA2001 vaccine
2022
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19: Place of the VidPrevtyn Beta vaccine
2022
∙
Haute Autorité de Santé
Booster vaccine strategy against Covid-19
2022
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19: Place of the Nuvaxovid vaccine in the booster strategy
2022
∙
Haute Autorité de Santé
Vaccination recommendation against Shingles - Concept note
2022
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19: role of the bivalent Spikevax Original / Omicron BA.4/BA.5 vaccine (mRNA-1273.222)
2022
∙
SAGE
Vaccines and immunization for monkeypox: WHO Interim guidance, 24 August 2022
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register
